Skip to main content
  • Newsletters
  • Axios Pro
  • Axios Live
  • The Axios Show
Axios

Axios

Katherine Davis

Katherine Davis is a biotech reporter for Axios Pro Deals. She reports on venture capital, private equity and M&A transactions across the biotech sector.

  • email[email protected]

Stories

    • Biotech Deals

    Apr 9, 2026

    Sanofi's Vnuk: More billion-dollar deals ahead

    Go deeper (1 min. read)
    • Biotech Deals

    Apr 7, 2026

    Colossal spinout Astromech raises $40.5M at $2B valuation

    Go deeper (1 min. read)
    • Biotech Deals

    Apr 7, 2026

    Gilead to buy Tubulis for up to $5B

    Go deeper (1 min. read)
    • Biotech Deals

    Apr 7, 2026

    Exclusive: Endovascular Engineering raises $80M for pulmonary embolism treatment

    Go deeper (1 min. read)
    • Biotech Deals

    Apr 3, 2026

    Citizens banker: Biopharma deal frenzy fuels optimism for 2026

    Go deeper (1 min. read)

Newsletter editions

    • Newsletter

    Apr 4, 2026

    🧬 Biotech weekly

    Go deeper (2 min. read)
    • Newsletter

    Mar 28, 2026

    🧬 Biotech weekly

    Go deeper (3 min. read)
    • Newsletter

    Mar 21, 2026

    🧬 Biotech weekly

    Go deeper (3 min. read)
    • Newsletter

    Mar 14, 2026

    🧬 Biotech weekly

    Go deeper (2 min. read)
    • Newsletter

    Mar 7, 2026

    🧬 Biotech weekly

    Go deeper (2 min. read)
Smarter, faster on what matters.
Explore Axios Newsletters
  • About Axios
  • Advertise with us
  • Careers
  • Contact us
  • Newsletters
  • Axios Live
  • Axios HQ
  • Privacy policy
  • Terms of use
Axios Homepage

Axios Media Inc., 2026